Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model
about
Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma modelHuman CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response.Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells.Mucin 1-specific active cancer immunotherapy with tecemotide (L-BLP25) in patients with multiple myeloma: an exploratory studyCytosine arabinoside promotes cytotoxic effect of T cells on leukemia cells mediated by bispecific antibody.In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway.Towards curative cancer immunotherapy: overcoming posttherapy tumor escape.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Targeting the bone marrow microenvironment in multiple myeloma.Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.Targeting the Bone Marrow Microenvironment.
P2860
Q34173568-B066077B-B583-49A0-BCA1-E02A5BA65B65Q35078064-1A559A96-1EC8-4A37-B725-5F6B41960137Q35668937-DBB22A46-E773-4706-9AFE-9D1600AC7ED3Q35886589-90F3A9B4-F9DA-46A9-9C0C-29C1FF0CA297Q37102166-753158CB-E159-4C39-95E7-6AE86FE73312Q37474087-0F30B5B4-13F4-4B6B-B43B-537B6BB81D5DQ38025094-6335BBFF-F357-463D-A98D-98F607AAE697Q38110540-6159DAAB-651A-4980-99F8-55CFB7F9EECDQ38289041-1089EB44-8219-4237-90E6-8FF271BA84F6Q38729516-CDEDE471-E1CF-4FAB-96EC-53CA02C49CE8Q38970585-955A4DF7-FE66-444A-AEB1-506CEDE2594B
P2860
Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model
description
article
@en
im Oktober 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2010
@uk
name
Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model
@en
Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model
@nl
type
label
Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model
@en
Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model
@nl
prefLabel
Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model
@en
Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model
@nl
P2093
P1476
Chemoimmunotherapy reduces the progression of multiple myeloma in a mouse model
@en
P2093
Asher Meshorer
Ayelet Laronne-Bar-On
Nechama Haran-Ghera
P304
P356
10.1158/1940-6207.CAPR-10-0138
P407
P50
P577
2010-08-18T00:00:00Z